WADHANE JITENDRA (SVP, Chief Accounting Officer) purchased 2.3% of their position (5K shares) of PYXIS ONCOLOGY, INC. on the open market
Open‑market purchase worth $8.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/25/2023ACC: 0001209191-23-050495
Officer· SVP, Chief Accounting Officer
Since Aug 2022
+5K
Net shares
Net buyer
$8.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$1.77
Trade value
$8.85K
% of position
2.3%
9/25/2023
219.44K→224.44K
Total
Net shares
+5K
Net value
$8.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/25/2023 | P · Purchase | +5K | $1.77 | $8.85K | 2.3% | 219.44K | 224.44K |
| Total | +5K | $8.85K | ||||||
Derivative Transactions0
No derivative transactions reported